1-[(Aryloxy)alkyl]-1H-imidazoles as inhibitors of neuronal nitric oxide synthase

Pharmacy and Pharmacology Communications

Volumn 5, Issue 8, 1999, Pages 491-494

  Salerno, L ^a   Sorrenti, V ^b   Guerrera, F ^b   Sarva M C ^b   Siracusa, M A ^b   Di Giacomo, C ^b   Vanella, A ^b  

^a UNIVERSITY OF CATANIA   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

IMIDAZOLE DERIVATIVE; NITRIC OXIDE SYNTHASE INHIBITOR;

ARTICLE; CONTROLLED STUDY; DRUG POTENCY; DRUG SELECTIVITY; ENZYME ACTIVITY; ENZYME INHIBITION; NONHUMAN;

EID: 0032857779     PISSN: 14608081     EISSN: None     Source Type: Journal    
DOI: 10.1211/146080899128735225     Document Type: Article

References (19)

1. Chabin, R. M., McCauley, E., Calaycay, J. R., Kelly, T. M., Mac Nau, K. L., Wolfe, G. C., Hutchinson, N. I., Madhusudanaraja, S., Schmidt, J. A., Kozarich, J. W., Wong, K. K. (1996) Active-site structure analysis of recombinant human inducible nitric oxide synthase using imidazole. Biochemistry 35: 9567-9575
2. Cross, P., Dickinson, R., Parry, M., Randall, M. (1985) Selective thromboxane synthetase inhibitors. 1. 1-[(Aryloxy) alkyl)]-1H-imidazoles. J. Med. Chem. 28: 1427-1432
3. Dixon, M. (1953) The determination of enzyme inhibitor constants. Biochem. J. 55: 170-171
4. Dou, H. J. M., Metzger, J. (1976) Catalyse par transfert de phase en sèrie hètèrocyclique. N-alkylation des pyrazole et imidazole. Bull. Soc. Chim. Fr. 11-12: 1861-1864
5. Hevel, J. M., Marietta, M. A. (1994) Nitric-oxide synthase assays. In: Packer, L. (ed) Methods in Enzymology, Academic Press, San Diego, pp 250-258
6. Kato, K., Ohkawa, S., Terao, S., Terashita, Z., Nishikawa, K. (1985) Thromboxane synthetase inhibitors (TXSI). Design, synthesis, and evaluation of a novel series of ω-pyridylalkenoic acids. J. Med. Chem. 28: 287-294
7. Kerwin, J. F., Lancaster, J. R., Feldman, P. L. (1995) Nitric oxide: a new paradigm for second messengers. J. Med. Chem. 38: 4343-4362
8. Macdonald, J. E. (1996) Nitric oxide synthase inhibitors. Annu. Rep. Med. Chem. 31: 221-230
9. Marletta, M. A. (1993) Nitric oxide synthase structure and mechanism. J. Biol. Chem. 268: 12231-12234
10. Marletta, M. A. (1994) Approaches toward selective inhibition of nitric oxide synthase. J. Med. Chem. 37: 1899-1907
11. Moncada, S., Palmer, R. M. J., Higgs, E. A. (1991) Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43: 109-142
12. Moore, P. K., Handy, R. L. C. (1997) Selective inhibitors of neuronal nitric oxide synthase - is no NOS really good NOS for the nervous system? Trends Pharmacol. Sei. 18: 204-211
13. Radomski, M. W., Palmer, R. M. J., Moncada, S. (1990) An L-arginine/nitric oxide pathway present in human platelets regulates aggregation. Proc. Natl Acad. Sci. USA 87: 5193-5197
14. Robertson, D. W., Beedle, E. E., Lawson, R., Leander, J. D. (1987) Imidazole anticonvulsants: stucture-activity relationships of [(biphenyloxy)alkyl]imidazoles. J. Med. Chem. 30: 939-943
15. Rogerson, T., Wilkinson, C., Hetarsky, K. (1976) Steric factors in the inhibitory interaction of imidazoles with microsomal enzymes. Biochem. Pharmacol. 26: 1039-1042
16. Salerno, L., Sorrenti, V., Guerrera, F., Sarvà, M. C., Siracusa, M. A., Di Giacomo, C., Vanella, A. (1999) N-substituted-imidazoles as inhibitors of nitric oxide synthase: a preliminary screening. Pharmazie: In press
17. Shimazu, K., Shimizu, M., Suzuki, K., Kuwano, E. (1996) Precocious methamorphosis-inducing activity of 1-substituted imidazoles. Nippon Noyaku Gakkaishi 21: 337-339
18. Southan, G. J., Szabò, C. (1996) Selective pharmacological inhibition of distinct nitric oxide synthase isoforms. Biochem. Pharmacol. 51: 383-394
19. Wolff, D. J., Datto, G. A., Samatovicz, R. A., Tempsick, R. A. (1993) Calmodulin-dependent nitric-oxide synthase. Mechanism of inhibition by imidazole and phenylimidazoles. J. Biol. Chem. 268: 9425-9429